Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California

 

Recent News and Articles on the Keywords: 0.29 + web + 202,000  Related to the article below (Last Update: 8/4/2008)

Anadarko Announces Second-Quarter Results
WELT ONLINE, Germany -
... 1798 2003 2000 Price per thousand cubic feet excluding derivatives $ 9.88 $ 6.14 $ 8.64 $ 6.19 Realized gain (loss) on derivatives (0.51 ) 0.47 (0.29 ...APC - BOM:500312 - WAR:CFL
TranS1 Inc. Reports Operating Results for the Second Quarter of 2008
CNNMoney.com (press release) - Jul 31, 2008
To access the live audio broadcast or the subsequent archived recording, visit the TranS1 Web site at www.trans1.com under the investor relations section. ...TSON
Exeter Resource Corporation: Drilling Locates Major Extensions to ...
CNNMoney.com - Jul 29, 2008
The report can be viewed on Exeter's web site (www.exeterresource.com) or on SEDAR (www.sedar.com). In this news release all intervals are calculated at a ...XRA - CVE:XRC
Are Dividends the Cure for Your Ailing Portfolio?
Morningstar.com, IL - Jul 29, 2008
It recently got a new manager, Michael Reckmeyer, but its ultralow 0.29% expense ratio means that it's still one of our favorites. ...
ESI Announces First Quarter Fiscal 2009 Results
MarketWatch - Jul 24, 2008
The audio replay will also be available on the ESI Web site. In this press release, we have presented financial measures which have not been determined in ...ESIO
ProEx Reports Second Quarter Results
Canada NewsWire (press release), Canada - Jul 29, 2008
The Asset Acquisition included approximately 2000 boe per day of production, 95 percent natural gas and approximately 80000 net acres of undeveloped land. ...TSE:PXE
Source: Google News

[PDF] Web Presence and Impact Factors for Middle-Eastern Countries Alireza Noruzi -
A Noruzi - eprints.rclis.org
... D Web pages indexed by Yahoo R-WIF (B/D) Revised Web Impact Factor ... Jordan 0.51 274000
154000 110000 538000 0.29 Cyprus 0.48 447000 233000 202000 931000 0.25 ...

[PDF] … Accumulation of Polychlorinated Biphenyl Congeners in the Terrestrial Food Web of the Kalamazoo … -
AL Blankenship, MJ Zwiernik, KK Coady, DP Kay, JL … - Environmental Science & Technology, 2005 - msu.edu
Differential Accumulation of Polychlorinated Biphenyl Congeners in the Terrestrial
Food Web of the ... This study focused on two locations for food web analysis. ...

[CITATION] Evaluation of Electronic Knowledge Repositories
T Chao, A Kankanhalli, BCY Tan
-

[PDF] When Every Vote Does Not Count: Electoral Rules and Environmental Policy
PG Fredriksson, DL Millimet - faculty.smu.edu
Page 1. 1 When Every Vote Does Not Count: Electoral Rules and Environmental
Policy Per G. Fredriksson Southern Methodist University ...

[CITATION] Comparative Politics and Environmental Taxation: Theory and Quasi-Experimental Evidence
PG Fredriksson, DL Millimet - 2002 - mimeo, Southern Methodist University, Department of Economics

[PDF] What do students know about work? -
A Beavis, D Curtis, N Curtis - Senior Secondary School Students? Perception of the World …, 2005 - smithfamily.com.au
Page 1. What do students know about work? SENIOR SECONDARY SCHOOL STUDENTS? PERCEPTIONS
OF THE WORLD OF WORK A report prepared for The Smith Family ...

[PDF] DRAFT DRAFT DRAFT DRAFT Performance-Oriented Patterns in Software Design (A multi-level service … -
CM Woodside - sce.carleton.ca
Page 1. 6 DRAFT DRAFT DRAFT DRAFT Performance-Oriented Patterns in Software
Design (A multi-level service approach) CM Woodside Dept. ...

[PDF] A skew item response model -
JL Baz?n, MD Branco, H Bolfarine - Bayesian Analysis, 2006 - ba.stat.cmu.edu
Page 1. Bayesian Analysis (2006) 1, Number 4, pp. 861?892 A Skew Item Response Model
Jorge L. Bazan * , Marcia D. Branco ? , and Heleno Bolfarine ? ...

[PDF] Interim Report IR-06-024 -
K Barrett, S Nilsson - iiasa.ac.at
... Laxenburg, Austria Tel: +43 2236 807 342 Fax: +43 2236 71313 E-mail:
publications@iiasa.ac.at Web: www.iiasa.ac.at Interim Reports ...

Ductility of G550 Sheet Steels in Tension-Elongation Measurements and Perforated Tests
CARBAS MASc, GJHBEBS PhD - civil.usyd.edu.au
Page 1. Department of Civil Engineering Sydney NSW 2006 AUSTRALIA http://www.
civil.usyd.edu.au/ Centre for Advanced Structural Engineering ...
-

Source: Google Scholar
 
 

Nevirapine resistance higher than previously thought

 
 
The incidence of drug resistance associated with single-dose Nevirapine ( Viramune ), a drug used to prevent mother-to-child transmission of HIV-1, may be substantially higher than previously thought and of particular risk for those infected with HIV-1 subtype C.

A single dose of Nevirapine given to an HIV-infected pregnant woman during delivery, and another given to her newborn, can cut the rate of mother-to-child HIV transmission in half. The relative simplicity and affordability of single-dose Nevirapine have made it the drug of choice for prevention of mother-to-child transmission in many developing countries.

This new research expands understanding of the risks of drug resistance associated with single-dose Nevirapine, but as noted by all three research groups, the clinical implications for patients are not yet clear. More research will be needed to determine whether Nevirapine used to prevent mother-to-child transmission affects the chances of successful treatment later with nonnucleoside reverse transcriptase inhibitors, the class of drug to which Nevirapine belongs.

Two of the studies analyzed the incidence of Nevirapine-associated resistance using laboratory tests more sensitive than standard genotypic assays.

In the first, researchers led by Jeffrey A. Johnson, of the Centers for Disease Control and Prevention, used a new, very sensitive technique to detect resistance mutations in samples of HIV-1 obtained from 50 South African women before and after treatment with single-dose Nevirapine.
Using a less-sensitive conventional technique called sequence analysis, researchers had previously estimated that viral resistance to Nevirapine emerged in approximately 40 percent of women after receiving the single-dose therapy.
In contrast, Johnson and colleagues concluded that resistance emerges in at least 65 percent of women after use of single-dose Nevirapine.
This finding indicates that more than one-third of the resistance that emerges from this intervention is undetected by conventional laboratory tests.

In the second study, a group headed by Susan H. Eshleman, of Johns Hopkins University, analyzed HIV samples from nine mothers and five infants in Uganda who had received single-dose Nevirapine.
The researchers used standard sequencing techniques and, like the first group of researchers, two more-sensitive assays.
The more-sensitive assays detected resistance mutations a year or more after use of single-dose Nevirapine, whereas the conventional assay could not detect resistance at one or two years.
Taken together, these two studies indicate that resistance after the single-dose therapy occurs more frequently and may persist longer in the circulation than previously thought.

The third study, also led by Eshleman, asked whether the rate of Nevirapine resistance differs according to HIV-1 subtype.
The researchers examined the rate of Nevirapine resistance after single-dose therapy in 65 women in Malawi infected with subtype C, the most common subtype in many developing countries where single-dose Nevirapine is used, as compared with that of 241 women in Uganda infected with subtypes A or D ( in the United States, B is the predominant subtype ).
Women in each subtype group had similar demographic characteristics.
The frequency of mutations associated with nonnucleoside reverse transcriptase inhibitors ( NNRTI ) was significantly higher in women with subtype C virus ( 69 percent ) than in those with subtype A ( 19 percent ) or subtype D ( 36 percent ).

In an accompanying editorial, Scott M. Hammer, of Columbia University, emphasized that these three studies raise questions for additional research, including whether the presence of Nevirapine-associated resistance mutations in women and children compromises the subsequent treatment of their HIV infection, or the subsequent use of single-dose Nevirapine in a second pregnancy.
As an alternative approach to single-dose Nevirapine, Hammer noted, combination therapies can reduce rates of newborn HIV infection while reducing the risk of resistance in the mother, but are more expensive and may require more health care infrastructure.

"As with any new medical intervention," Hammer said, " there are inevitable tradeoffs with single-dose Nevirapine. Although no major safety issues have arisen in mothers or infants taking this therapy, the emergence of drug resistance has created an increasing challenge to the scientific and public health communities."

Source: The Journal of Infectious Diseases, 2005
 
 
 
Google
Web www.iconocast.com
 
 
 

 

ALL THE NEWS : News1 ; News2 ; News3 ; News4 ; News5 ; News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services. Home

 © 2002-2006

Keywords::

Contact Iconocast

Home Page